Literature DB >> 24801540

The clinical role of serum concentrations of selected cytokines: IL-1β, TNF-α and IL-6 in diagnosis of autoimmune thyroid disease (AITD) in children.

Hanna Mikos1, Marcin Mikos, Barbara Rabska-Pietrzak, Marek Niedziela.   

Abstract

Chronic autoimmune thyroiditis (cAIT) leads to hypothyroidism due to T cell-mediated cytotoxicity in most cases. By contrast, Graves' disease (GD) with thyrotropin receptor stimulatory autoantibodies cause hyperthyroidism. Cytokines play a crucial role in modulating immune response in both disorders. The aim of study was to evaluate the concentrations of cytokines: IL-1β, TNF-α and IL-6 in these two opposite clinical and hormonal thyroid diseases. The study group consisted of 64 children, 44 newly diagnosed, untreated children with cAIT (n = 22; with hypothyroidism) and GD (n = 22; hyperthyroidism), and the control group of 20 healthy children. Cytokine concentrations were evaluated using the ELISA technique. The studied groups of children did not differ significantly in concentrations of IL-6 (p = 0.48) and TNF-α (p = 0.067). In children with hypothyroidism, we found significantly higher concentrations of IL-1β (median 2.16 pg/ml, IQR 0.87) compared to hyperthyroidism (median 1.39 pg/l, IQR 1.27) (p < 0.01) and the control group (median 1.88 pg/ml, IQR 1.04) (p < 0.05). The results of ROC curve analysis demonstrated the usefulness of IL-1β (AUC = 0.77, p = 0.003) and TNF-α (AUC = 0.691, p = 0.034) as diagnostic parameters in cAIT which enable discrimination of children with autoimmune thyroid disease from healthy individuals. Concentrations of these markers are increased in autoimmune hypothyroidism. We found no significant sex differences in the tested parameters. In conclusion, IL-1β and TNF-α may be considered as markers of hypothyroidism, and could efficiently discriminate between healthy and autoimmune hypothyroid children. Significantly higher concentrations of IL-1β in children with hypothyroidism may be used to distinguish children with cAIT from GD patients.

Entities:  

Keywords:  Autoimmunity; children; cytokines; serum; thyroid

Mesh:

Substances:

Year:  2014        PMID: 24801540     DOI: 10.3109/08916934.2014.914175

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  5 in total

1.  Low vitamin D levels are associated with cognitive impairment in patients with Hashimoto thyroiditis.

Authors:  Jun Xu; Xiang-Yun Zhu; Hui Sun; Xiao-Qin Xu; Song-Ao Xu; Yuan Suo; Li-Jun Cao; Qiang Zhou; Hui-Jie Yu; Wei-Zhong Cao
Journal:  BMC Endocr Disord       Date:  2018-11-26       Impact factor: 2.763

2.  Changes in glucose-lipid metabolism, insulin resistance, and inflammatory factors in patients with autoimmune thyroid disease.

Authors:  Yi Lei; Jun Yang; Hua Li; Haihua Zhong; Qin Wan
Journal:  J Clin Lab Anal       Date:  2019-07-27       Impact factor: 2.352

3.  Assessment of the Effect of Selenium Supplementation on Production of Selected Cytokines in Women with Hashimoto's Thyroiditis.

Authors:  Jadwiga Kryczyk-Kozioł; Ewelina Prochownik; Anna Błażewska-Gruszczyk; Marian Słowiaczek; Qian Sun; Lutz Schomburg; Ewa Ochab; Mirosław Bartyzel; Paweł Zagrodzki
Journal:  Nutrients       Date:  2022-07-13       Impact factor: 6.706

4.  Circulating Visfatin in Hypothyroidism Is Associated with Free Thyroid Hormones and Antithyroperoxidase Antibodies.

Authors:  Nadia Sawicka-Gutaj; Ariadna Zybek-Kocik; Aleksandra Klimowicz; Michał Kloska; Dorota Mańkowska-Wierzbicka; Jerzy Sowiński; Marek Ruchała
Journal:  Int J Endocrinol       Date:  2016-01-17       Impact factor: 3.257

5.  Dysregulated Antibody, Natural Killer Cell and Immune Mediator Profiles in Autoimmune Thyroid Diseases.

Authors:  Tiphaine C Martin; Kristina M Ilieva; Alessia Visconti; Michelle Beaumont; Steven J Kiddle; Richard J B Dobson; Massimo Mangino; Ee Mun Lim; Marija Pezer; Claire J Steves; Jordana T Bell; Scott G Wilson; Gordan Lauc; Mario Roederer; John P Walsh; Tim D Spector; Sophia N Karagiannis
Journal:  Cells       Date:  2020-03-09       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.